Please use this identifier to cite or link to this item:
Scopus Web of ScienceĀ® Altmetric
Type: Journal article
Title: Methaemoglobinaemia secondary to topical lignocaine/prilocaine in a circumcised neonate
Author: Couper, R.
Citation: Journal of Paediatrics and Child Health, 2000; 36(4):406-407
Publisher: Blackwell Publishing Asia
Issue Date: 2000
ISSN: 1034-4810
Abstract: The use of topical lignocaine/prilocaine (EMLA, Astra Pharmaceuticals, North Ryde, NSW, Australia) for pain relief for neonatal circumcision is becoming more prevalent. Because of immaturity of the methaemoglobin reductase pathway, the neonate is vulnerable to methaemoglobinaemia which is a recognized complication of prilocaine therapy. This is the second report of methaemoglobinaemia due to the use of EMLA in association with circumcision during the newborn period.
Keywords: Humans; Methemoglobinemia; Lidocaine; Prilocaine; Anesthetics, Combined; Anesthetics, Local; Infant, Newborn; Male; Circumcision, Male; Lidocaine, Prilocaine Drug Combination
RMID: 0001003048
DOI: 10.1046/j.1440-1754.2000.00508.x
Appears in Collections:Paediatrics publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.